Nabriva Therapeutics AG (NBRVF)

Last Closing Price: 1.42 (2023-07-31)

Expense Ratio (Annual)

Expense Ratio: A measure of profitability used by an insurance company to indicate how well it is performing in its daily operations. The expense ratio is calculated by taking the operating expenses and then dividing them by earned premium. Calculated as: (Total Operating Expenses - Underwriting Losses Total) / Net Premiums Earned

Nabriva Therapeutics AG (NBRVF) Expense Ratio data is not available.

Figures for fiscal year ending 2022-12-31
Income Statement Financials
$36.94M
$-57.19M
$28.58M
$8.35M
$92.42M
$-55.49M
$-0.13M
$-55.62M
$-55.62M
$-57.19M
$-57.19M
$-57.19M
$-57.19M
$-55.49M
$-55.27M
26.82M
26.82M
$-2.13
$-2.13
Balance Sheet Financials
$31.10M
$0.28M
$0.66M
$31.77M
$27.61M
$0.39M
$0.87M
$28.47M
$3.29M
$3.29M
$3.29M
32.01M
Cash Flow Statement Financials
$-36.71M
$-0.26M
$1.85M
$47.83M
$12.54M
$-35.30M
$1.97M
--
--
Fundamental Metrics & Ratios
1.13
--
--
0.11
1.59
22.62%
-150.24%
-150.24%
-149.65%
-150.58%
-154.83%
$-36.92M
--
Expense Ratio
--
--
1.16
2.95
5.48
66.63
-1736.60%
-1738.15%
-180.03%
-1553.52%
$0.10
$-1.38
$-1.37